Two published experiments reached different practical observations because they tested different peptides and solutions.
What the study actually tested
One mass-spectrometry handling study compared a peptide mixture kept at 4 °C, aliquots frozen and thawed once, and a sample put through ten freeze–thaw cycles. Aliquots were prepared at 1 pmol/µL in water with 3% acetonitrile and 0.1% formic acid; the authors injected 50 fmol per LC–MS/MS run. They reported broadly comparable mean peak areas, while variability was highest after ten cycles. A separate stability study tested the connexin43 mimetic peptide Cx43MP and measured 89.03% recovery after its defined two-cycle procedure.
Numbers worth reading in context
| Study measure | Reported result |
|---|---|
| Mixture study | 10 cycles |
| Cx43MP study | 2 cycles |
| Cx43MP recovery | 89.03% |
A cycle count without a sequence, matrix, concentration, endpoint, and acceptance range is not a stability claim. The mixture study compared peak-area behavior of assay peptides under one solvent system; the Cx43MP value was recovery of a particular peptide under another protocol. It would be incorrect to average the results or conclude that two cycles are always worse than ten.
A reporting inconsistency to keep visible
The Cx43MP paper states 89.03% recovery in both its discussion and Table 3. However, the same table lists 247.54 µg/mL remaining from an initial 250 µg/mL, which calculates to approximately 99.02%, not 89.03%. We preserve 89.03% as the authors’ reported percentage, not an independently reconciled recovery value. The discrepancy makes it unsuitable as an acceptance threshold for another peptide.
What to put in the RFQ or experiment plan
For a critical experiment, pre-aliquot the working solution and document thaw temperature, time, number of cycles, and the measured endpoint. If you need an allowed cycle count from a supplier, ask which lot, method, formulation, and acceptance criterion support it. Keep a fresh or single-thaw comparator when testing your own workflow.
Evidence boundary
Neither publication establishes freeze–thaw stability for an NHD lot. The second study also reports other stresses, but its severe acid/base conditions should not be generalized into routine shipping instructions.
Sources and next step
Primary research: Recommendations for the generation, quantification, storage and handling of peptides used for mass spectrometry-based assays; Development of a stability-indicating RP-HPLC method for a Connexin43 mimetic peptide. These external figures are not test results for an NHD lot.
Related NHD guide: read the related article. For a material-specific question, request a written quotation with the sequence, amount, intended use, and required records.
Sources & editorial method
AI-assisted writing and source verification. Numerical claims were checked against the linked full-text records, with source inconsistencies identified in the article. This is not independent scientific peer review or verification of a supplied lot.
2 linked records are listed in the references below. Read the editorial and AI-assistance policy.
How to interpret this article
Neither publication establishes freeze–thaw stability for an NHD lot. The second study also reports other stresses, but its severe acid/base conditions should not be generalized into routine shipping instructions.
Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.
